Literature DB >> 19458910

Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.

Neslihan Edeer Karaca1, Guzide Aksu, Ferah Genel, Nesrin Gulez, Sema Can, Yesim Aydinok, Serap Aksoylar, Emin Karaca, Imren Altuglu, Necil Kutukculer.   

Abstract

Severe combined immunodeficiencies (SCID) comprise a spectrum of genetic defects that involve both humoral and cellular immunities. Defects in recombinating activating gene 1 (RAG1), RAG2, Artemis, or LIG4 can disrupt V(D)J recombination. Defective V(D)J recombination of the T and B cell receptors is responsible for T(-)B(-)NK(+)SCID. Amorphic mutations in RAG1 and RAG2 cause T(-)B(-)NK(+)SCID, whereas hypomorphic mutations cause an immunodeficency characterized by oligoclonal expansion of TCRgammadelta T cells, severe CMV infection and autoimmunity. First patient is a typical T(-)B(-)NK(+)SCID with clinical and immunologic findings while the second is atypical with normal immunoglobulin levels, CD4 lymphopenia, elevated TCRgammadelta T cells, persistent CMV infection, and autoimmune hemolytic anemia. These cases are presented to emphasize that mutations in RAG1 gene may lead to a diverse spectrum of clinical and immunologic findings while hypomorphic mutations may be related with autoimmunity and refractory CMV infection during infancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458910     DOI: 10.1007/s10238-009-0053-1

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  14 in total

Review 1.  V(D)J recombination.

Authors:  David G Schatz
Journal:  Immunol Rev       Date:  2004-08       Impact factor: 12.988

2.  Biochemical and folding defects in a RAG1 variant associated with Omenn syndrome.

Authors:  Carrie Simkus; Priyanka Anand; Anamika Bhattacharyya; Jessica M Jones
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

3.  GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T-B- SCID in patients with defects in RAG genes.

Authors:  Iram J Haq; Laura J Steinberg; Manfred Hoenig; Mirjam van der Burg; Anna Villa; Andrew J Cant; Peter G Middleton; Andrew R Gennery
Journal:  Clin Immunol       Date:  2007-06-14       Impact factor: 3.969

4.  Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.

Authors:  Taizo Wada; Tomoko Toma; Hiroyuki Okamoto; Yoshihito Kasahara; Shoichi Koizumi; Kazunaga Agematsu; Hirokazu Kimura; Akira Shimada; Yasuhide Hayashi; Masahiko Kato; Akihiro Yachie
Journal:  Blood       Date:  2005-04-21       Impact factor: 22.113

Review 5.  RAG-dependent primary immunodeficiencies.

Authors:  Cristina Sobacchi; Veronica Marrella; Francesca Rucci; Paolo Vezzoni; Anna Villa
Journal:  Hum Mutat       Date:  2006-12       Impact factor: 4.878

6.  A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.

Authors:  Mirjam van der Burg; Lieneke R van Veelen; Nicole S Verkaik; Wouter W Wiegant; Nico G Hartwig; Barbara H Barendregt; Linda Brugmans; Anja Raams; Nicolaas G J Jaspers; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

7.  Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.

Authors:  D Moshous; I Callebaut; R de Chasseval; B Corneo; M Cavazzana-Calvo; F Le Deist; I Tezcan; O Sanal; Y Bertrand; N Philippe; A Fischer; J P de Villartay
Journal:  Cell       Date:  2001-04-20       Impact factor: 41.582

8.  RAG mutations in human B cell-negative SCID.

Authors:  K Schwarz; G H Gauss; L Ludwig; U Pannicke; Z Li; D Lindner; W Friedrich; R A Seger; T E Hansen-Hagge; S Desiderio; M R Lieber; C R Bartram
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

9.  European experience of bone-marrow transplantation for severe combined immunodeficiency.

Authors:  A Fischer; P Landais; W Friedrich; G Morgan; B Gerritsen; A Fasth; F Porta; C Griscelli; S F Goldman; R Levinsky
Journal:  Lancet       Date:  1990-10-06       Impact factor: 79.321

10.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

Authors:  Jean-Pierre de Villartay; Annick Lim; Hamoud Al-Mousa; Sophie Dupont; Julie Déchanet-Merville; Edith Coumau-Gatbois; Marie-Lise Gougeon; Arnaud Lemainque; Céline Eidenschenk; Emmanuelle Jouanguy; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

View more
  8 in total

1.  Consanguinity rate and delay in diagnosis in Turkish patients with combined immunodeficiencies: a single-center study.

Authors:  Elif Azarsiz; Nesrin Gulez; Neslihan Edeer Karaca; Guzide Aksu; Necil Kutukculer
Journal:  J Clin Immunol       Date:  2010-10-06       Impact factor: 8.317

2.  A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency.

Authors:  Hassan Abolhassani; Ning Wang; Asghar Aghamohammadi; Nima Rezaei; Yu Nee Lee; Francesco Frugoni; Luigi D Notarangelo; Qiang Pan-Hammarström; Lennart Hammarström
Journal:  J Allergy Clin Immunol       Date:  2014-07-02       Impact factor: 10.793

3.  Hypomorphic Rag mutations can cause destructive midline granulomatous disease.

Authors:  Suk See De Ravin; Edward W Cowen; Kol A Zarember; Narda L Whiting-Theobald; Douglas B Kuhns; Netanya G Sandler; Daniel C Douek; Stefania Pittaluga; Pietro L Poliani; Yu Nee Lee; Luigi D Notarangelo; Lei Wang; Frederick W Alt; Elizabeth M Kang; Joshua D Milner; Julie E Niemela; Mary Fontana-Penn; Sara H Sinal; Harry L Malech
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

4.  Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders.

Authors:  David Buchbinder; Rebecca Baker; Yu Nee Lee; Juan Ravell; Yu Zhang; Joshua McElwee; Diane Nugent; Emily M Coonrod; Jacob D Durtschi; Nancy H Augustine; Karl V Voelkerding; Krisztian Csomos; Lindsey Rosen; Sarah Browne; Jolan E Walter; Luigi D Notarangelo; Harry R Hill; Attila Kumánovics
Journal:  J Clin Immunol       Date:  2014-12-17       Impact factor: 8.317

5.  Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency.

Authors:  Jan Rohr; Ulrich Pannicke; Michaela Döring; Annette Schmitt-Graeff; Elisabeth Wiech; Andreas Busch; Carsten Speckmann; Ingo Müller; Peter Lang; Rupert Handgretinger; Paul Fisch; Klaus Schwarz; Stephan Ehl
Journal:  J Clin Immunol       Date:  2009-12-05       Impact factor: 8.317

6.  Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus.

Authors:  Inés G Muñoz; Jesús Prieto; Sunita Subramanian; Javier Coloma; Pilar Redondo; Maider Villate; Nekane Merino; Marco Marenchino; Marco D'Abramo; Francesco L Gervasio; Sylvestre Grizot; Fayza Daboussi; Julianne Smith; Isabelle Chion-Sotinel; Frédéric Pâques; Philippe Duchateau; Andreu Alibés; François Stricher; Luis Serrano; Francisco J Blanco; Guillermo Montoya
Journal:  Nucleic Acids Res       Date:  2010-09-16       Impact factor: 16.971

7.  Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency.

Authors:  Necil Kutukculer; Nesrin Gulez; Neslihan Edeer Karaca; Guzide Aksu; Afig Berdeli
Journal:  Ital J Pediatr       Date:  2012-03-16       Impact factor: 2.638

8.  Placental transfer of maternally-derived IgA precludes the use of guthrie card eluates as a screening tool for primary immunodeficiency diseases.

Authors:  Stephan Borte; Magdalena Janzi; Qiang Pan-Hammarström; Ulrika von Döbeln; Lennart Nordvall; Jacek Winiarski; Anders Fasth; Lennart Hammarström
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.